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Abstract
Objectives: To estimate the prevalence, incidence and determinants of herpes simplex type 2 (HSV-2) infection, and
associations between HSV-2 and incident HIV infection, among women at higher risk for HIV infection in Beira, Mozambique.
Methods: Between 2009 and 2012, 411 women aged 18–35 years at higher risk of HIV acquisition (defined as having had
two or more sexual partners in the month prior to study enrollment) were enrolled and followed monthly for one year. At
each study visit, they were counseled, interviewed, and tested for HSV-2 and HIV antibodies.
Results: The HSV-2 prevalence at baseline was 60.6% (95% CI: 55.7% –65.4%). Increasing age (aOR= 2.94, 95% CI: 1.74–4.97,
P,0.001 and aOR= 3.39, 95% CI: 1.58–7.29, P= 0.002 for age groups of 21–24 and 25–35 years old respectively), lower
educational level (aOR= 1.81, 95% CI: 1.09–3.02, P= 0.022), working full time (aOR= 8.56, 95% CI: 1.01–72.53, P= 0.049) and
having practiced oral sex (aOR= 3.02, 95% CI: 1.16–7.89, P= 0.024) were strongly associated with prevalent HSV-2 infection.
Thirty one participants seroconverted for HSV-2 (20.5%; 95% CI: 14.4% –27.9%) and 22 for HIV during the study period. The
frequency of vaginal sex with a casual partner using a condom in the last 7 days was independently associated with incident
HSV-2 infection (aOR= 1.91, 95% CI: 1.05–3.47, P= 0.034). Positive HSV-2 serology at baseline was not significantly
associated with risk of subsequent HIV seroconversion.
Conclusions: Young women engaging in risky sexual behaviors in Beira had high prevalence and incidence of HSV-2
infection. Improved primary HSV-2 control strategies are urgently needed in Beira.
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Introduction
Herpes simplex virus type-2 (HSV-2) infection is a chronic
sexually transmitted infection (STI) and the main cause of genital
ulcer disease (GUD) worldwide [1–3]. This infection constitutes a
substantial public health problem in sub-Saharan Africa because it
increases the risk of HIV acquisition two to four fold [2,4–6].
HSV-2 and HIV have a synergistic relationship in that HSV-2
infection increases the susceptibility to and transmission of HIV,
while HIV infection increases the susceptibility to HSV-2 infection
and HSV-2 genital shedding [3,7–9].
Reported risk factors for prevalent HSV-2 include older age
[7,8,10], greater lifetime number of sexual partners [10,11],
working in bars and hotels [7,12], prevalent HIV-1 infection,
recent GUD or STI symptoms [10,13], lower educational level
[11,14] and female gender [10,13]. HSV-2 prevalence and
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incidence are generally high among young African women,
particularly those who engage in risky sexual behaviors, including
exchanging sex for money or goods [9,12,14,15].
Studies in Southern Africa have shown variation in the
prevalence of HSV-2 across diverse populations: 39.8%, 42.2%
and 49.1% among male factory workers, urban and pregnant
women in Zimbabwe, respectively [16–18]; 84% among female
sex workers at truck stops in South Africa [15]; and 28% and
54.4% among GUD patients and male farm workers in Zambia,
respectively [19,20]. No population-based HSV-2 data are
available for Mozambique.
Mozambique is a country severely affected by HIV/AIDS, with
a 2009 national prevalence estimated at 11.5% among adults aged
15–49 years and 13.1% among women of the same age [21].
Sofala Province (of which Beira is the capital) had the highest HIV
prevalence of 15.5% among adults aged 15–49 years and 17.8%
among women [21]. Only 2% of women aged 15–49 years in
Sofala province had two or more sexual partners in the last 12
months [21]. However, the HIV prevalence among this group was
32.6%, almost double the provincial rate among all women [22].
According to the National Strategic HIV and AIDS Response
Plan 2010–2014, multiple sexual partners along with low condom
usage are the main drivers of HIV acquisition in Mozambique and
contribute to approximately 24–29% of all HIV new infections in
the country [23].
The main aim of our study was to estimate HIV prevalence and
incidence among HIV-seronegative women reporting two or more
sexual partners in the past month in Beira, Mozambique, in
preparation for clinical trials of new HIV prevention interventions.
HSV-2 prevalence and incidence were also assessed given the
synergies between the two infections. Here, we focus on the HSV-
2 results and the association between HSV-2 infection and HIV
seroconversion in this study population.
Materials and Methods
Ethics Statement
The study was approved by the National Ethics Committee
(Comite´ Nacional de Bioe´tica para a Sau´de or CNBS) in Maputo,
Mozambique, the Protection of Human Subjects Committee
(PHSC) at FHI 360, Durham, NC, USA, and the Division of
Human Subjects Protection of the Walter Reed Army Institute of
Research (WRAIR), Washington, DC, USA. The current analysis
was further approved by the School of Population Health Ethics
Committee of the University of Queensland, Brisbane, Australia.
Literate participants provided written informed consent for the
cross-sectional survey and the prospective cohort study; illiterate
participants provided a thumb print and brought a literate witness
who signed the consent form on their behalf. Participants received
approximately 5 USD reimbursement per scheduled study visit.
Study Design and Population
Between December 2009 and September 2012, a total of 1,018
women aged 18–35 years reporting at least two sexual partners in
the past month participated in a cross-sectional survey in Beira,
Mozambique [22]. HIV-negative women were offered enrollment
in a prospective cohort study and the first 411 eligible women who
consented were enrolled. Additional eligibility criteria included
Mozambican citizenship, unknown HIV status, no history of
antiretroviral therapy or non-therapeutic injecting drug use, and
not currently enrolled in another HIV-related research study.
Detailed recruitment procedures have been described elsewhere
[22]. Briefly, women were recruited from the community by
outreach workers in places considered to be of potential high risk
of HIV sexual acquisition, such as bars, barracks, kiosks,
nightclubs, formal and informal markets, long-distance truck
driver parking and secondary schools in and around the
municipality of Beira. For virtually all women, enrollment into
the longitudinal study occurred within 30 days of the cross-
sectional survey visit. The small number of women who returned
more than 30 days after their cross-sectional survey visit was
required to repeat the survey procedures.
Study Procedures
Participants were followed up monthly over a 12-month period.
At baseline and at each monthly follow-up visit, trained nurses
conducted a face-to-face interview to obtain information about
demographics, socio-economic status, sexual and contraceptive
behavior and presence of STI symptoms. Blood samples were
collected at each study visit for HIV and HSV-2 testing. HIV
testing was performed at each study visit while the participant was
at the study clinic using a rapid HIV test algorithm whereas HSV-
2 testing was done in batches on baseline samples and on study
exit samples (final study visit or HIV seroconversion visit) if the
baseline sample was negative. Blood samples from participants
who seroconverted for HIV were also tested by CD4 cytometry
and HIV-1 RNA PCR. A urine pregnancy test was performed at
every study visit. All participants received pre- and post-HIV test
and safer sex counseling as well as male and female condoms free
of charge. Participants who reported STI symptoms were given
syndromic treatment according to the Mozambican Ministry of
Health guidelines and pregnant women were referred to antenatal
care [24].
Laboratory Methods
HSV-2 serological testing was performed at the UCM-CIDI
Laboratory in Beira using the HerpeSelect 2 ELISA IgG assay
(Focus Diagnostics, Cypress, CA, USA) following the manufac-
turer’s instructions. HIV rapid testing was performed in the
research center in the presence of the study participant using the
Determine HIV1/2 rapid test (Alere Medical Co. Ltd., Chiba,
Japan) as a screening test and Uni-Gold (Trinity Biotech PLC,
Bray, Ireland) as a confirmatory test. The SD Bioline HIV-1/2 3.0
rapid test (Standard Diagnostics Inc., Kyonggi-do, Korea) and/or
ELISA were used to resolve discrepant rapid test results.
Participants who tested HIV-positive received a CD4 count from
the study clinic and were referred to public health centers to access
HIV care. CD4 counts were determined on an EDTA blood
sample at the clinical laboratory of the ‘‘Centro de Sau´de Urbano
Ponta-Geˆa’’ using a BD FACSCalibur flow cytometry platform.
Pregnancy testing was done by rapid urine hCG pregnancy test
(Healthease Preg n Care, NEOMED IPA, Tzaneen, South Africa).
Statistical Analysis
All data were recorded on standardized case report forms that
were double-entered into a database. Data were analyzed using
STATA software version 11.2 (Statacorp, College Station, TX,
USA).
Categorical variables were expressed as percentages, and
continuous variables as medians with inter-quartile ranges
(IQR). Baseline HSV-2 prevalence was calculated as the number
of participants who tested positive for HSV-2 at cohort enrollment
divided by the number of enrolled participants. HSV-2 incidence
was calculated as the number of women who seroconverted for
HSV-2 during follow-up divided by the total number of HSV-2
seronegative women at cohort enrollment [26].
Bivariable logistic regression models were used to assess
determinants of prevalent baseline HSV-2 infection one at a time
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in two subgroups: demographic/socioeconomic factors and sexual
behavioral factors. All factors associated with HSV-2 infection at
p#0.20 in the bivariable analyses were included in explanatory
multivariable logistic regression models. The first multivariable
model included demographic/socioeconomic factors only (Model
I) and the second model sexual behavior factors only (with age
forced into the model due to its importance as a confounder:
Model II). Finally, variables with p#0.20 in Models I and II were
combined into a final multivariable model (Model III). The same
modeling approach was used to assess determinants of HSV-2
incidence (comparing women who seroconverted for HSV-2 to
those who remained negative, and excluding those who tested
HSV-2 positive at baseline) with HSV-2 seroconversion as the
outcome.
Figure 1. Participant flow diagram describing numbers enrolled, numbers tested for HSV-2 prevalence, and numbers included for
HSV-2 incidence.
doi:10.1371/journal.pone.0089705.g001
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Table 1. Determinants of baseline HSV-2 prevalence among 409 women, Beira, Mozambique.
Variablea n # HSV-2 positive/ Unadjusted OR
(Prevalence, %) 95% CI p
Total 409b 248 (60.6)
Age group (years)
18–20 179 78 (43.6) Referent
21–24 145 102 (70.3) 3.07 (1.93–4.88) ,0.001
25–35 85 68 (80.0) 5.18 (2.82–9.51) ,0.001
Age of first marriage (years)
Never married 205 106 (51.7) Referent
#17 69 50 (72.5) 2.46 (1.36–4.46) 0.003
$18 124 87 (70.2) 2.2 (1.37–3.52) 0.001
Education
High school (grade 10–12) 132 67 (50.8) Referent
Secondary school (grade 6–9) 229 145 (63.3) 1.67 (1.08–2.59) 0.020
Primary school (grade1–5) or none 48 36 (75.0) 2.91 (1.39–6.08) 0.005
Employment status
Unemployed 297 170 (57.2) Referent
Employed part time 92 59(64.1) 1.33 (0.82–2.17) 0.241
Employed full time 20 19 (95.0) 14.19 (1.88–107.43) 0.010
Income last month (Mt)c
No income 268 152 (56.7) Referent
$500 61 38 (62.3) 1.26 (0.71–2.23) 0.427
501–15,000 72 54 (75.0) 2.29 (1.27–4.11) 0.006
Number of lifetime pregnancies
0 124 55 (44.4) Referent
1 108 58 (53.7) 1.46 (0.87–2.44) 0.156
$2 177 135 (76.3) 4.03 (2.46–6.62) ,0.001
Family planning use
None 268 152 (56.7) Referent
Hormonal contraceptives 95 68 (71.6) 1.92 (1.16–3.19) 0.012
Other d 46 28 (59.6) 1.19 (0.63–2.25) 0.599
Age at first sexual intercourse (years)
$18 102 68(66.7) Referent
16–17 163 85(52.2 0.54 (0.33–0.91) 0.021
#15 136 91(66.9) 1.01 (0.59–1.74) 0.968
Age of primary partner (years)
No PP 24 13 (54.2) Referent
Yes, aged 29 and younger 295 167 (56.6) 1.10 (0.48–2.55) 0.816
Yes, aged 30 and older 77 62 (80.5) 3.50 (1.31–9.33) 0.012
Ever exchanged sex
No 350 206 (58.9) Referent
Yes 58 41 (70.7) 1.69 (0.92–3.08) 0.090
Forced to have sex in the last month
No 363 224 (61.7) Referent
Yes 42 21 (50.0) 0.62 (0.33–1.18) 0.144
PP had sex with others in the last 6 months
No 111 61 (55.0) Referent
Yes 258 168 (65.1) 1.53 (0.97–2.41) 0.066
Oral sex with PP in the last month
No 378 224(59.3) Referent
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A survival analysis using Kaplan-Meier curves and the log-rank
test was used to compare the HIV seroconversion curves of women
who were HSV-2 seropositive and seronegative at baseline.
Bivariable analysis with Cox proportional hazard models was
used to calculate hazard ratios (HR) and 95% confidence intervals
(CI) for baseline HSV-2 status and time-varying HSV-2 status
during follow-up as a determinant of HIV acquisition. The
proportional hazard assumption was tested and was valid. The two
models (one for baseline HSV-2 status and one for time-varying
HSV-2 status) had similar goodness of fit based on martingale
residuals.
Results
Characteristics of the Study Population
The first 411 HIV-negative cross-sectional survey participants
who consented were enrolled in the prospective cohort study. Two
women were excluded from all analyses: one woman had missing
data at baseline and another did not meet the inclusion criterion of
two or more sexual partners in the last month (Figure 1). The
overall retention rate in the cohort study was 80%.
The median age of the participants was 21.0 years (IQR 19–24
years). About half of the participants (50.5%) were single and
56.0% had completed secondary school (grade 6–9). The majority
of women (72.6%) were unemployed and 66.2% had no income in
the last month. Forty three percent of women had been pregnant
at least twice and 65.5% did not use a method of family planning.
One third of the participants (33.3%) had sex for the first time at
age 15 years or younger. More than two-thirds of women (70.4%)
reported two sexual partners in the last month with the remaining
29.6% reporting three or more sexual partners. The majority of
women (94.1%) reported to have a primary sexual partner, defined
as a spouse, cohabitating partner, or a partner that the woman
herself considered to be her most important partner. All other
partners, including commercial partners, were defined as casual
partners. About two-thirds of women (63.1%) reported that their
primary partners had had sex with others in the last 6 months.
Condom use was very low in this study population, with 79.9%
and 57.0% of women reporting not having used condoms in the
last month with a primary or casual partner, respectively. Oral and
anal sex were relatively uncommon in this population (reported by
7.4% and 3.9% of women, respectively). The majority of the
participants reported never having exchanged sex for money or
goods (85.8%) or having been forced to have sex against their will
(89.0%).
Baseline HSV-2 Seroprevalence and Determinants
The HSV-2 seroprevalence at baseline was 60.6% (95%
CI = 55.7–65.4%). In bivariable logistic regression analysis,
HSV-2 seroprevalence increased significantly with age, age at
first marriage, lower level of education, working full-time, having a
higher income, having had two or more lifetime pregnancies and
currently using hormonal contraceptives (Table 1). HSV-2
prevalence was also significantly higher among those whose
primary partner was 30 years or older and those who did not use a
condom during vaginal sex with a primary partner during the last
month (Table 1). Prevalent HSV-2 infection was significantly
lower in those who had sex for the first time at age 16–17
compared to those who were older.
In the final multivariable model, age was most strongly
associated with baseline HSV-2 prevalence (adjusted odds ratio
(aOR) = 2.94, 95% CI: 1.74–4.97, P,0.001 and aOR = 3.39, 95%
CI: 1.58–7.29, P= 0.002 for age groups of 21–24 and 25–35 years
old respectively). Other determinants of HSV-2 prevalence were
having had secondary school (grade 6–9) compared to high school
(grade 10–12) education (aOR = 1.81, 95% CI: 1.09–3.02,
P= 0.022), working full-time (aOR = 8.56, 95% CI: 1.01–72.53,
P= 0.049) and having practiced oral sex (aOR = 3.02, 95% CI:
1.16–7.89, P = 0.024) (Model III, Table 2). Having a primary
partner who had sex with others in the last 6 months was not
significant (aOR = 1.67, 95% CI: 0.99–2.80, P= 0.053). Con-
versely, having been forced to have sex in the last month was
associated with reduced HSV-2 prevalence (aOR = 0.31, 95% CI:
0.15–0.66, P= 0.003).
Table 1. Cont.
Variablea n # HSV-2 positive/ Unadjusted OR
(Prevalence, %) 95% CI p
Yes 30 23(76.7) 2.26 (0.95–5.39) 0.067
Frequency of vaginal sex with PP using condom in the last
month
Any use 82 41 (50.0) Referent
None 326 206 (63.2) 1.72 (1.05–2.80) 0.030
Pain during intercourse
No 322 203 (63.0) Referent
Yes 88 46 (52.3) 0.64 (0.40–1.03) 0.068
OR, odds ratio; CI, Confidence intervals; PP, primary partner; CP, casual partner;
HSV-2, Herpes simplex virus type-2.
The total number of missing answers is 74.
? The following variables were also assessed for their association with prevalent HSV-2 but were not significant at the p,0.2 level in bivariable models:
Categorical variables: number of sexual partners, number of new sexual partners, oral sex with CP last month, anal sex with PP last month, anal sex with CP last month
and frequency of vaginal sex with CP using condom last month.
Continuous variables: frequency of vaginal sex with PP last month, frequency of vaginal sex with CP last month, frequency of vaginal sex with PP using condom last 7
days and frequency of vaginal sex with CP using condom last 7 days.
bTotals for the categories are not always equal to 409 because of missing data.
c1 USD= 29.70 Meticais (Mt) as per 29/03/2013 (Millennium bim Bank).
dOther Condoms/Copper IUD/Traditional.
doi:10.1371/journal.pone.0089705.t001
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Table 2. Multivariable models of factors associated with HSV-2 prevalence in high risk women in Beira, Mozambique.
Variable MODEL I n =402 MODEL II n=404 MODEL III n=406
Adjusted OR P Adjusted OR p Adjusted OR p
95% CI 95% CI 95% CI
Age group (years)
18–20 Referent Referent Referent
21–24 2.68 (1.60–4.47) ,0.001 3.22 (1.91–5.44) ,0.001 2.94 (1.74–4.97) ,0.001
25–35 2.89 (1.36–6.13) 0.006 4.95 (2.22–11.02) ,0.001 3.39 (1.58–7.29) 0.002
Age first marriage (yrs)
Never married Referent
17 or less (#17) 0.98 (0.46–2.07) 0.959
18 and older ($18) 0.82 (0.44–1.52) 0.527
Education
Grade 10–12 Referent Referent
Grade 6–9 1.61 (0.97–2.66) 0.063 1.81 (1.09–3.02) 0.022
Grade1–5 or none 1.93 (0.83–4.49) 0.124 2.24 (0.94–5.36) 0.069
Employment status
Unemployed Referent Referent
Employed part time 1.03 (0.55–1.93) 0.934 0.93 (0.53–1.61) 0.793
Employed full time 5.21 (0.63–43.27) 0.127 8.56 (1.01–72.53) 0.049
Income last month (Mt)1
.500 Referent
#500 0.81 (0.36–1.86) 0.625
No income 0.87 (0.43–1.79) 0.708
# lifetime pregnancies
0 Referent Referent
1 1.30 (0.73–2.33) 0.379 1.11 (0.62–1.97) 0.725
$2 2.20 (1.09–4.45) 0.028 1.72 (0.91–3.26) 0.094
Family planning use
None Referent
Hormonal contraceptives 1.18 (0.66–2.10) 0.579
Othera 1.28 (0.64–2.58) 0.489
Age at first sex (years)
$18 Referent
16–17 0.77 (0.42–1.39) 0.383
#15 1.48 (0.79–2.76) 0.222
Don’t know 0.47 (0.10–2.29) 0.349
Age of PP (years)
No PP Referent
Yes, ,30 0.77 (0.27–2.18) 0.629
Yes, $30 0.93 (0.27–3.22) 0.916
Ever exchanged sex
Never Referent Referent
Yes 1.60 (0.81–3.16) 0.177 1.66 (0.83–3.32) 0.154
Forced to have sex in the last month
No Referent Referent
Yes 0.38 (0.18–0.81) 0.012 0.31 (0.15–0.66) 0.003
PP sex with others in the last 6
months
No Referent Referent
Yes 1.52 (0.92–2.51) 0.104 1.67 (0.99–2.80) 0.053
HSV-2 Infection among High Risk Women in Beira
PLOS ONE | www.plosone.org 6 February 2014 | Volume 9 | Issue 2 | e89705
HSV-2 Incidence and Determinants
Of 161 women who were HSV-2 negative at baseline, 151
women were tested for HSV-2 during the follow-up period. Thirty
one of them (20.5%) seroconverted for HSV-2 during follow-up.
In bivariable and multivariable analyses, HSV-2 acquisition
during follow-up was significantly associated with frequency of
vaginal sex with a casual partner using a condom in the last 7 days
(OR = 1.86, 95% CI 1.03–3.38, P = 0.041; aOR = 1.91, 95% CI:
1.05–3.47, P = 0.034). For women who were 21–24 years
compared to women who were 18–20 years, the aOR for HSV-
2 incidence was 2.36 (95% CI: 0.98–5.71, P = 0.057). (Model III;
Table 3).
Associations between HSV-2 Infection and HIV
Seroconversion
Two hundred forty eight of 409 women were HSV-2 positive at
baseline, of which 233 (94.0%) remained HIV-negative and 15
(6.1%) became infected with HIV during follow-up. Among the 22
women with HIV seroconversion during the 12-month follow-up
period, 15 (68.2%) were HSV-2 positive at baseline, 2 (9.1%)
seroconverted for HSV-2, and 5 (22.7%) remained uninfected
during the follow-up period. Figure 2 shows Kaplan-Meier curves
for time to HIV seroconversion according to HSV-2 status at
baseline. The logrank test did not reach statistical significance
(P= 0.406). A bivariable Cox regression model between HSV-2
status at baseline and subsequent HIV seroconversion showed a
HR of 1.40 (95% CI: 0.57–3.44, P = 0.461). The relationship
between HSV-2 serostatus at baseline and HIV seroconversion
was not investigated further by multivariable analysis due to non-
significant findings in bivariable analyses.
Of 31 women who seroconverted for HSV-2, 2 (6.5%) also
seroconverted for HIV and 29 (93.6%) remained HIV negative
during the follow-up period. A Cox regression model using time-
varying HSV-2 as predictor was used to assess the associations
between incident HSV-2 infection and incident HIV infection.
The model showed a HR of 1.64 (95% CI: 0.61–4.46, P= 0.329).
Discussion
This is the first study to assess prevalence, incidence, and
determinants of HSV-2 infection in young, urban women in
Mozambique at high risk of HIV infection. Women in this study
had a high HSV-2 prevalence (ranging from 43.9% to 80.0%
depending on the age group) and 20.5% seroconverted over a 12-
month period, which is similar to rates found among high-risk
women in other sub-Saharan African countries [7,9,27,28]. These
data suggest that interventions aimed at primary prevention of
HSV-2, such as promotion of safer sexual behaviors, in young
Mozambican women are urgently needed.
Increasing age was significantly associated with an increased
HSV-2 seroprevalence and HSV-2 incidence, which is consistent
with results of other African studies [7,14,27,28]. Findings of the
present study also add to the evidence that lower education,
having a full time job, and having a primary partner who had sex
with others in the last 6 months increased the risk of HSV-2
infection, although the latter not significantly. Most of the women
in this study were working in informal settings, particularly in sales,
food service and manual labor in bars, barracks and markets, and
working full-time in these settings might be associated with
exposure to multiple sexual partners. Studies among bar and hotel
workers showed that these women are vulnerable because they
engage in risky sexual behaviors [7,9,29].
Surprisingly, having been forced to have sex in the last month
was associated with a lower risk of HSV-2 prevalent infection in
this study population. The association between HSV-2 infection
Table 2. Cont.
Variable MODEL I n =402 MODEL II n=404 MODEL III n=406
Adjusted OR P Adjusted OR p Adjusted OR p
95% CI 95% CI 95% CI
Not applicable, no PP 0.68 (0.28–1.64) 0.391 0.91 (0.40–2.08) 0.819
Oral sex with PP
No Referent Referent
Yes 3.03 (1.17–7.80) 0.022 3.02 (1.16–7.89) 0.024
Frequency vaginal sex with PP using
condom in the last month
Any use Referent Referent
None 1.61 (0.92–2.81) 0.094 1.47 (0.83–2.60) 0.189
Pain during intercourse in the past 3
months
No Referent Referent
Yes 0.55 (0.32–0.95) 0.031 0.62 (0.36–1.06) 0.081
R2 0.1203 0.1374 0.1586
AIC 507.182 501.9356 492.8155
BIC 575.1217 569.9597 560.9235
R2, Coefficient of Determination; AIC, Akaike Information Criterion; BIC, Bayesian Information Criterion;
Model I refers to the multivariable analysis of demographic/socioeconomic factors only;
Model II refers to the multivariable analysis of sexual behavior factors only, adjusted for age;
Model III refers to the multivariable analysis of both subgroups using cut off of P,0.20 in Models I and II.
a‘Other’ Condoms/copper IUD/Traditional methods.
doi:10.1371/journal.pone.0089705.t002
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and being forced to have sex against one’s will could have been
confounded by other factors such as age and other sexual
behavioral factors; this finding should therefore be interpreted
with caution.
Oral sex was associated with a 4-fold increased risk of baseline
HSV-2 prevalence in this population. A study among high-risk
(imprisoned) women in Iran found a significant association
between anal and oral sex and a positive HSV-2 IgG test result,
suggesting that HSV-2 can be transmitted through anal and oral
sex [30]. Reporting oral sex might also be associated with
engaging in exchanging sex for money or other high-risk sexual
behaviors. Having practiced vaginal sex with a casual partner
using a condom in the last 7 days was associated with an increase
in risk of HSV-2 acquisition in our study population. This may
suggest that there was inconsistent use of condoms among the
participants and their casual partners or overreporting of condom
use due to social desirability bias. Reporting of condom use might
reflect sexual risk-taking behavior [12].
Various studies have suggested positive associations between
prevalent and incident HSV-2 infection with incident HIV
infection [5,16,31]. Our findings also show trends in that direction,
but did not reach statistical significance. We believe that this is
most likely due to limited statistical power (22 HIV seroconver-
sions translates into 11% statistical power to detect an association
between incident HSV-2 infection and incident HIV infection),
but it is also possible that an association between HSV-2 and HIV
infection does not exist in our study setting.
Other limitations of our study include the possibility of selection
and social desirability biases, and a lack of generalizability to all
women in Beira due to recruitment of high risk women with two or
more sexual partners only. In addition, studies suggest that the
HerpeSelect HSV-2 IgG assay has lower specificity in African
than Western populations [25,32,33]. The authors of these studies
have hypothesized that this may be due to cross-reactivity with
HSV-1 or differences in circulating HSV-2 strains [25,32,33]. We
did not confirm positive HerpeSelect HSV-2 results with another
test to improve specificity, which may have resulted in some false-
positive test results. The HSV-2 prevalence and incidence in our
study may therefore have been overestimated.
In conclusion, this study confirms that HSV-2 prevalence and
incidence among young women at risk for HIV in Beira,
Mozambique, is high and is associated with increasing age and
high risk sexual behaviors. In the absence of an HSV-2 vaccine,
health campaigns among young people should promote condom
Table 3. Multivariable models of factors associated with HSV-2 incidence in high risk women in Beira, Mozambique.
MODEL I n=146 MODEL II n=151 MODEL III n=151
Variablea aOR (95% CI) p aOR (95% CI) p aOR (95% CI) P
Age group (years)
18–20 Referent Referent Referent
21–24 1.92 (0.73–5.06) 0.185 2.27 (0.92–5.58) 0.074 2.36 (0.98–5.71) 0.057
25–35 0.82 (0.17–3.94) 0.802 1.39 (0.34–5.67) 0.644 1.37 (0.34–5.55) 0.657
Age of first marriage (years)
Never married Referent
17 or less(#17) 0.40 (0.07–2.18) 0.290
18 and older ($18) 1.53 (0.47–4.92) 0.477
# lifetime pregnancies
0 Referent
1 0.70 (0.15–2.72) 0.606
$2 0.51 (0.17–1.70) 0.271
Frequency of vaginal sex with a
PP in the last month*
1.00 (0.95–1.06) 0.956
Frequency of vaginal sex with a
CP using a condom in the
last 7 days*
1.82 (0.94–3.52) 0.075 1.91 (1.05–3.47) 0.034
Anal sex with CP last month
No Referent
Yes 2.59 (0.26–24.35) 0.421
R2 0.052 0.055 0.0503
AIC 157.13 156.89 153.6
BIC 178.01 174.99 165.67
aOR, Adjusted Odds Ratio; *Continuous variables; R2, Coefficient of Determination; AIC, Akaike Information Criterion; BIC, Bayesian Information Criterion; PP, Primary
Partner; CP, Casual Partner.
aThe following variables were also assessed for their association with incident HSV-2 but were not significant at the p,0.2 level in bivariable models:
Categorical variables: education, employment status, family planning use, age at first sexual intercourse (years), number of sexual partners in the last month, number of
new sexual partners in the last month, age of PP (years), ever exchanged sex, forced to have sex in the last month, PP had sex with others last 6 months, oral sex with PP
in the last month, anal sex with PP in the last month, anal sex with CP in the last month, frequency of vaginal sex with PP using condom in the last month and frequency
of vaginal sex with CP using condom in the last month.
Continuous variables: frequency vaginal sex with CP using condom in the last 7 days, frequency of vaginal sex with PP in the last month and frequency of vaginal sex
with CP in the last month.
doi:10.1371/journal.pone.0089705.t003
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use, reduction in numbers of sexual partners, and a delay of sexual
debut. HSV-2 prevention and counseling should be given high
priority on the Mozambican health agenda, and should be
addressed along with HIV and other STIs as part of a
comprehensive prevention package.
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